Oorsprong van het eerstegraads netwerk van Sten Bay Jørgensen
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Unibio International Plc
Unibio International Plc Financial ConglomeratesFinance Unibio International Plc is a leading British sustainable protein company that specializes in producing single-cell protein for animal feed. The company is based in London, UK, and David Henstrom has been the CEO since 2021. The company has won several awards for its environmentally friendly practices, including the "Kalundborg Business Council's Green Environment and Climate Award." Unibio has participated in various exhibitions and conferences worldwide, including the "Forum for Innovations in Agriculture" in 2018 and the "Deutsche Messe Hannover" in 2018.
6
| Holding Company | Financial Conglomerates | 6 |
Unibio AS
Unibio AS BiotechnologyHealth Technology Unibio AS is a Danish biotechnology company that operates in an undisclosed location. The private company was founded in 2001, and its CEOs are Jakob Brix Christensen, Sten Bay Jørgensen, and David Richard Henstrom.
4
| Private Company | Biotechnology | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Sten Bay Jørgensen via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Evolva SA
Evolva SA Miscellaneous Commercial ServicesCommercial Services Evolva SA is a Swiss-headquartered, international pharmaceutical biotech company focused on the discovery and development of drugs based on its distinctive and proprietary genetic chemistry platform. The company was founded in Switzerland in 2004 based on US/Danish technology. Evolva is headquartered in Allschwil/Basel with operations in Denmark, India and the USA. The Company has raised CHF 38.2 million of equity to date and employs 75 persons of whom 30 are based in Allschwil. The firm's strategy and business approach is based on five pillars that offer a sustainable development path for creating a successful company, which include Building a balanced portfolio. Evolva focuses on orally available small molecules in the belief that they are more convenient for patients and more cost-effective both from manufacture and administration points of view for the society, focus on differentiated pharmaceutical products with major benefits. Focusing on cardiovascular/renal and infectious diseases. Together they cause more than 50% of all deaths worldwide. Most of the top 20 pharmaceutical companies are active in both sectors, and all are active in one of the two sectors - hence widening Evolva's opportunities to partner. Building technology platform as the source of this differentiation. Evolva finds different structures with different properties from those found by the 99% of the industry that focuses on synthetic chemistry or proteins. Openness to unusual markets. The biotech business model has changed. As well as the established markets new opportunities arise in emerging countries such as India and China, and in adjacent sectors such as treatments against potential bio-terrorist and bio-warfare agents and the production of pharmaceutical and industrial chemical intermediates. Cost-effective implementation. Evolva places different functions around the globe according to where local conditions best suit. This approach both reduces Evolva's cost base and increases access to revenues, partners and talent. Evolva sees revenues and partners as important because they provide additional flexibility, resources and talent. Also, they provide important opportunities to better understand, and better meet, the needs of current and future customers. | Miscellaneous Commercial Services | Founder | |
Sundew ApS
Sundew ApS Packaged SoftwareTechnology Services Sundew ApS targets water-borne pests and diseases. The company is based in Copenhagen, Denmark. and has subsidiaries in Ireland. The Danish company was founded in 2018 by Neil Goldsmith, Jørgen Hansen, Andy Gardiner. Giovanni Salerno has been the CEO of the company since 2021. | Packaged Software | Founder | |
CLEAN POWER HYDROGEN PLC | Oilfield Services/Equipment | Chief Executive Officer | |
Maersk Growth
Maersk Growth Investment ManagersFinance Maersk Growth (Maersk Growth) is the venture capital arm of the listed company A.P. Møller-Mærsk A/S (CPH:MAERSK). The firm was founded in 2017 and is headquartered in Copenhagen, Denmark. | Investment Managers | Private Equity Investor | |
Vivostat A/S
Vivostat A/S Medical SpecialtiesHealth Technology Vivostat A/S provides cardiac, thoracic and orthopaedic surgery medical devices. It offers vivostat system, an automated system for the on-site preparation and application of patient-derived fibrin sealant or platelet rich fibrin. Its products include Vivostat autologous fibrin sealant for various settings in surgical areas, transfusion centers, or blood banks and Vivostat platelet rich fibrin, which utilizes the patient's own blood to derive either a surgical sealant to prevent and stop bleedings, or a gel with a high concentration of growth factors that stimulates the healing of chronic wounds, as well as provides application devices. The compnay was founded in 2001 by Tom Bjerg Lauritzen and Niels Hvid and is headquartered in Alleroed, Denmark. | Medical Specialties | Director/Board Member | |
Sunstone Capital A/S
Sunstone Capital A/S Investment ManagersFinance Sunstone Capital A/S (Sunstone) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2007 by Peter Benson, Sten Verland, and Søren Lemonius, and invests on behalf of a group of institutional investors. | Investment Managers | Director of Finance/CFO | |
Puris Proteins LLC
Puris Proteins LLC Agricultural Commodities/MillingProcess Industries Puris Proteins LLC produces plant-based, non-GMO sustainable food ingredients. The firm?s products include pea starch, whole pea hull fiber, pea syrup, whole pulse powders, whole grains and ready to eat pea fiber. The company is headquartered in Minneapolis, MN. | Agricultural Commodities/Milling | Director/Board Member | |
Council for Responsible Nutrition | Director/Board Member | ||
Albumedix A/S
Albumedix A/S Pharmaceuticals: MajorHealth Technology Albumedix A/S is a Danish biotechnology company. The private company is based in Copenhagen, Denmark. | Pharmaceuticals: Major | Corporate Officer/Principal | |
BIOPORTO A/S | Medical Specialties | Director of Finance/CFO | |
Origio A/S
Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark. | Biotechnology | Public Communications Contact | |
CHOSA ONCOLOGY AB | Miscellaneous Commercial Services | Chairman | |
Chosa ApS
Chosa ApS Miscellaneous Commercial ServicesCommercial Services Chosa ApS is a Danish company that provides biotechnology services. The private company is based in Copenhagen, Denmark. The CEOs are Claus Frisenberg Pedersen and Neil Goldsmith. The company was founded in 2022. | Miscellaneous Commercial Services | Chief Executive Officer | |
Double Bioventures Ltd.
Double Bioventures Ltd. Miscellaneous Commercial ServicesCommercial Services Double Bioventures Ltd. is a British company founded in 2018 that builds non-traditional life-science companies in non-traditional ways. The private company is based in London, UK. The company focuses on identifying opportunities outside core therapeutics and developing robust business models for such businesses. The company aims to help life-science ventures play a wider role in meeting the challenges of the modern world. | Miscellaneous Commercial Services | Director/Board Member | |
Alentis Therapeutics AG
Alentis Therapeutics AG Pharmaceuticals: MajorHealth Technology Alentis Therapeutics AG develops novel medications to treat advanced liver diseases and cancers. The company was founded by Neil Goldsmith on March 1, 2019 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Founder | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
Balliol College | College/University | Undergraduate Degree | |
BIOTAGE AB | Medical Specialties | Founder | |
Quadrant Healthcare Plc
Quadrant Healthcare Plc Pharmaceuticals: MajorHealth Technology Part of Perrigo Co. Plc, Quadrant Healthcare Plc is a British company that researches, develops, and formulates drugs. The company is based in Cambridge, UK. Quadrant Healthcare was acquired by Elan Europe Ltd. on January 11, 2001 for $69.60 million. | Pharmaceuticals: Major | Director/Board Member | |
PNA Diagnostics A/S
PNA Diagnostics A/S Medical SpecialtiesHealth Technology PNA-Diagnostics A/S manufactures medical diagnostic equipment. The firm is a subsidiary of Applera Corp. The company is headquartered in Copenhagen, Denmark | Medical Specialties | President | |
GX Biosystems A/S | President | ||
Auda Pharmaceuticals ApS
Auda Pharmaceuticals ApS Miscellaneous Commercial ServicesCommercial Services Part of Phytera, Inc., Auda Pharmaceuticals ApS provides proprietary combinatorial chemistry technologies. Auda Pharmaceuticals was acquired by Phytera, Inc. from Danish Development Finance Corp on March 17, 1997. | Miscellaneous Commercial Services | President | |
EVOLVA HOLDING SA | Food: Specialty/Candy | Founder | |
Clean Power Hydrogen Group Ltd.
Clean Power Hydrogen Group Ltd. Medical SpecialtiesHealth Technology Clean Power Hydrogen Group Ltd. develops hydrogen production and storage equipment. The company was founded on July 19, 2016 and is headquartered in London, the United Kingdom. | Medical Specialties | Chief Executive Officer |
Statistieken
Internationaal
Denemarken | 14 |
Verenigd Koninkrijk | 7 |
Verenigde Staten | 5 |
Zwitserland | 4 |
Zweden | 4 |
Sectoraal
Health Technology | 12 |
Commercial Services | 8 |
Finance | 3 |
Process Industries | 3 |
Technology Services | 2 |
Operationeel
Director/Board Member | 17 |
Chief Executive Officer | 10 |
Founder | 6 |
Chairman | 6 |
Corporate Officer/Principal | 3 |
Sterkste connecties
- Beurs
- Insiders
- Sten Bay Jørgensen
- Bedrijfsconnecties